Related Experiment Video
Updated: Feb 15, 2026

Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy
Published on: November 29, 2018
An update on first line therapies for metastatic breast cancer
Palma Fedele1, Mariangela Ciccarese2, Giammarco Surico2
1a Medical Oncology & Breast Unit , 'Antonio Perrino' Hospital , Brindisi , Italy.
Introduction:
In recent years, outcomes of patients with metastatic breast cancer (MBC) have improved due to a greater understanding of the mechanisms of carcinogenesis in the development of newer molecularly targeted drugs, especially those as a front-line therapy. Remarkable improvements have been made in the treatment of hormone receptor positive (HR+) and Her2 positive MBC and currently targeted treatment strategies represent a valid first line treatment.
Areas Covered:
Herein, the authors provide an overview of the first-line pharmacotherapies currently available for the treatment of MBC and provide their expert perspectives on the area.
Expert Opinion:
Decisions on the first-line treatment of MBC should consider the clinical features of the disease, but also the biological mechanisms that regulate tumor cell growth. New and effective therapeutic agents have recently been introduced in the first-line therapy of MBC. However, to optimize the treatment of patients with metastatic disease, clinicians need biomarkers of resistance or sensitivity to targeted therapies. Efforts must also be made in developing strategies to personalize treatments of MBC patients and to identify those patients who might gain the most benefit from new treatment interventions, to save costs and limit toxicity.
Insights
Advances in understanding cancer mechanisms have led to improved outcomes for metastatic breast cancer (MBC) patients through targeted therapies. First-line treatments for HR+ and HER2+ MBC now significantly benefit from these molecularly targeted drugs.
Area of Science:
- Oncology
- Pharmacology
- Genetics
Background:
- Metastatic breast cancer (MBC) outcomes have improved due to molecularly targeted drugs.
- Significant advancements are noted in treating hormone receptor-positive (HR+) and HER2-positive MBC.
- Targeted treatment strategies are now a valid first-line option for MBC.
Purpose of the Study:
- To provide an overview of current first-line pharmacotherapies for MBC.
- To offer expert perspectives on the evolving landscape of MBC treatment.
- To highlight the importance of understanding biological mechanisms in treatment decisions.
Main Methods:
- Review of current first-line pharmacotherapies for MBC.
- Analysis of clinical features and biological mechanisms influencing treatment.
- Expert opinion on personalized treatment strategies and biomarker development.
Main Results:
- New and effective therapeutic agents have been introduced for first-line MBC therapy.
- Targeted treatments represent a valid first-line approach for HR+ and HER2+ MBC.
- The need for biomarkers to guide personalized treatment and optimize outcomes is emphasized.
Conclusions:
- First-line treatment decisions for MBC require consideration of both clinical and biological factors.
- Personalized treatment strategies and biomarker identification are crucial for optimizing MBC patient care.
- Developing strategies to identify patients who benefit most from new interventions is essential to manage costs and toxicity.
More Related Videos
06:52Monitoring Breast Cancer Growth and Metastatic Colony Formation in Mice using Bioluminescence
Published on: November 5, 2021
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Gene Therapy
Group Therapy
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Drug Therapy
Antianxiety Medications